TrialBMC medical genetics2011

Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study.

Samuel T Henderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.